TNF-α Signals Through PKCζ/NF-κB to Alter the Tight Junction Complex and Increase Retinal Endothelial Cell Permeability
Open accessThe DOI matches its Crossref record; 55 of the 57 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Tumor necrosis factor-α (TNF-α) and interleukin-1 beta (IL-1β) are elevated in the vitreous of diabetic patients and in retinas of diabetic rats associated with increased retinal vascular permeability. However, the molecular mechanisms underlying retinal vascular permeability induced by these cytokines are poorly understood. In this study, the effects of IL-1β and TNF-α on retinal endothelial cell permeability were compared and the molecular mechanisms by which TNF-α increases cell permeability were elucidated. RESEARCH DESIGN AND METHODS: Cytokine-induced retinal vascular permeability was measured in bovine retinal endothelial cells (BRECs) and rat retinas. Western blotting, quantitative real-time PCR, and immunocytochemistry were performed to determine tight junction protein expression and localization. RESULTS: IL-1β and TNF-α increased BREC permeability, and TNF-α was more potent. TNF-α decreased the protein and mRNA content of the tight junction proteins ZO-1 and claudin-5 and altered the cellular localization of these tight junction proteins. Dexamethasone prevented TNF-α–induced cell permeability through glucocorticoid receptor transactivation and nuclear factor-kappaB (NF-κB) transrepression. Preventing NF-κB activation with an inhibitor κB kinase (IKK) chemical inhibitor or adenoviral overexpression of inhibitor κB alpha (IκBα) reduced TNF-α–stimulated permeability. Finally, inhibiting protein kinase C zeta (PKCζ) using both a peptide and a novel chemical inhibitor reduced NF-κB activation and completely prevented the alterations in the tight junction complex and cell permeability induced by TNF-α in cell culture and rat retinas. CONCLUSIONS: These results suggest that PKCζ may provide a specific therapeutic target for the prevention of vascular permeability in retinal diseases characterized by elevated TNF-α, including diabetic retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These molecules function to promote leukocyte recruitment, adhesion, and infiltration through the blood-retinal barrier, ultimately resulting in a breakdown of retinal immune privilege.15,16”
From Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina (2021) · cites this paper as [15]
Experimental — accuracy not yet measuredIn the citing paper
“Furthermore, neurovascular damage induced by the peripheral myeloid cells, pro-inflammatory cytokines, and the dysregulation of the complement pathways could be a further potential mechanism of action [36,37,38].”
From C-Reactive protein as a biomarker for major depressive disorder? (2022) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · cited 1×
“0 RQ software and the 2 Ct analysis method (31), with glyceraldehyde-3-phosphate dehydrogenase (Bt03210919_g1) as the endogenous control.”
MethodBatlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917 · cited 1×
“Gene deletion studies have shown claudin-5 to be essential for blood–brain barrier function (25), and likely for the BRB as well.”
BackgroundSignalling to and from tight junctions
Matter, K., & Balda, M. S. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1055 · Cited by 884 · cited 1×
“Tight junctions are composed of a combination of more than 40 proteins including the transmembrane proteins occludin, the claudin family, and the junction adhesion molecule (JAM) family, several peripheral membrane-associated proteins, including members of the zonula occludens (ZO) family, and several regulatory prote…”
BackgroundUmeda, K., Ikenouchi, J., Katahira-Tayama, S., Furuse, K., Sasaki, H., Nakayama, M., Matsui, T., Tsukita, S., Furuse, M., & Tsukita, S. (2006) · Cell · doi:10.1016/j.cell.2006.06.043 · Cited by 823 · cited 1×
“Recent studies demonstrated that ZO proteins are essential for the formation and organization of tight junction complex assembly (26,27).”
BackgroundMiyamoto, K., Khosrof, S., Bursell, S.-E., Rohan, R., Murata, T., Clermont, A. C., Aiello, L. P., Ogura, Y., & Adamis, A. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10836 · Cited by 788
Antonetti, D. A., Barber, A. J., Bronson, S. K., Freeman, W. M., Gardner, T. W., Jefferson, L. S., Kester, M., Kimball, S. R., Krady, J. K., LaNoue, K. F., et al. (2006) · Diabetes · doi:10.2337/db05-1635 · Cited by 746
Self-citationAntonetti, D. A., Barber, A. J., Hollinger, L. A., Wolpert, E. B., & Gardner, T. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23463 · Cited by 686
Self-citationIkenouchi, J., Matsuda, M., Furuse, M., & Tsukita, S. (2003) · Journal of Cell Science · doi:10.1242/jcs.00389 · Cited by 678
The 14-year incidence of visual loss in a diabetic population,
Moss, S. (1998) · Ophthalmology · doi:10.1016/s0161-6420(98)96025-0 · Cited by 672
Aiello, L. P., Bursell, S.-E., Clermont, A., Duh, E., Ishii, H., Takagi, C., Mori, F., Ciulla, T. A., Ways, K., Jirousek, M., et al. (1997) · Diabetes · doi:10.2337/diab.46.9.1473 · Cited by 665
(2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.06.052 · Cited by 614
Regulation of protein kinase C ζ by PI 3-kinase and PDK-1
Chou, M. M., Hou, W., Johnson, J., Graham, L. K., Lee, M. H., Chen, C.-S., Newton, A. C., Schaffhausen, B. S., & Toker, A. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70444-0 · Cited by 608
Glial reactivity, an early feature of diabetic retinopathy.
Rungger‐Brändle, E., Dosso, A., & Leuenberger, P. (2000) · PubMed · Cited by 581
Antonetti, D. A., Barber, A. J., Khin, S., Lieth, E., Tarbell, J. M., & Gardner, T. W. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1953 · Cited by 577
Self-citationNonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression
M. Joussen, A., Poulaki, V., Mitsiades, N., Kirchhof, B., Koizumi, K., Döhmen, S., & P. Adamis, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0707fje · Cited by 567 · cited 3×
“The inhibition of TNF- with etanercept, a soluble TNF- receptor, inhibits NF- B activation, leukostasis, and BRB breakdown in diabetic rat retinas (12).”
BackgroundKrady, J. K., Basu, A., Allen, C. M., Xu, Y., LaNoue, K. F., Gardner, T. W., & Levison, S. W. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1559 · Cited by 529 · cited 1×
“Increased levels of interleukin-1 beta (IL-1 ) and tumor necrosis factor- (TNF- ) have been detected in the vitreous of diabetic patients with proliferative diabetic retinopathy (10,11) and in diabetic rat retinas (6,7,12).”
BackgroundActivation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition
Julien, S., Puig, I., Caretti, E., Bonaventure, J., Nelles, L., van Roy, F., Dargemont, C., de Herreros, A. G., Bellacosa, A., & Larue, L. (2007) · Oncogene · doi:10.1038/sj.onc.1210546 · Cited by 476
Demircan, N., Safran, B. G., Soylu, M., Ozcan, A. A., & Sizmaz, S. (2006) · Eye · doi:10.1038/sj.eye.6702138 · Cited by 395 · cited 2×
“Elevated levels of proinflammatory cytokines IL-1 and TNF- have been detected in the vitreous of diabetic patients with retinopathy (10,11) and in diabetic rat retinas correlated with increased vascular permeability (12,40).”
BackgroundMurakami, T., Felinski, E. A., & Antonetti, D. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016766 · Cited by 372 · cited 2×
“Louis, MO) was measured exactly as described previously (24).”
BackgroundMethodSelf-citationTargeted Disruption of the ζPKC Gene Results in the Impairment of the NF-κB Pathway
Leitges, M., Sanz, L., Martin, P., Duran, A., Braun, U., Garcı́a, J. F., Camacho, F., Diaz-Meco, M. T., Rennert, P. D., & Moscat, J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00361-6 · Cited by 371
Barber, A. J., Antonetti, D. A., & Gardner, T. W. (2000) · PubMed · Cited by 353
Self-citationFörster, C., Burek, M., Romero, I. A., Weksler, B., Couraud, P., & Drenckhahn, D. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.146852 · Cited by 307 · cited 1×
“These studies are consistent with previous publications demonstrating reduced claudin-5 gene expression after TNF- treatment in brain capillary endothelial cells (42,43).”
ResultKatsuno, T., Umeda, K., Matsui, T., Hata, M., Tamura, A., Itoh, M., Takeuchi, K., Fujimori, T., Nabeshima, Y.-I., Noda, T., et al. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-12-1215 · Cited by 297 · cited 1×
“Recent studies demonstrated that ZO proteins are essential for the formation and organization of tight junction complex assembly (26,27).”
BackgroundMartínez-Estrada, O. M., Cullerés, A., Soriano, F. X., Peinado, H., Bolós, V., Martínez, F. O., Reina, M., Cano, A., Fabre, M., & Vilaró, S. (2006) · Biochemical Journal · doi:10.1042/bj20050591 · Cited by 295
Expression from the human occludin promoter is affected by tumor necrosis factor α and interferon γ
Mankertz, J., Tavalali, S., Schmitz, H., Mankertz, A., Riecken, E. O., Fromm, M., & Schulzke, J. D. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.11.2085 · Cited by 287
Sensitive blood-retinal barrier breakdown quantitation using Evans blue.
Xu, Q., Qaum, T., & Adamis, A. P. (2001) · PubMed · Cited by 274
Leal, E. C., Manivannan, A., Hosoya, K.-I., Terasaki, T., Cunha-Vaz, J., Ambro´sio, A. F., & Forrester, J. V. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0112 · Cited by 247 · cited 1×
“The content of occludin and ZO-1 decreases in the retinas of diabetic animals (18,33,41).”
BackgroundSelf-citationHarhaj, N. S., Felinski, E. A., Wolpert, E. B., Sundstrom, J. M., Gardner, T. W., & Antonetti, D. A. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0322 · Cited by 238 · cited 3×
“Because conventional PKC isoforms contribute to the VEGF-induced permeability in retinal endothelial cells (23), the contributions of conventional and novel PKC isoforms for TNF- – induced cell permeability were also evaluated.”
BackgroundSelf-citationMiyarnoto, K. (1999) · Medical Entomology and Zoology · Cited by 207
Cytokines in the Vitreous of Patients With Proliferative Diabetic Retinopathy
Abu El Asrar, A. M., Maimone, D., Morse, P. H., Gregory, S., & Reder, A. T. (1992) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)74052-8 · Cited by 186 · cited 2×
“Elevated levels of proinflammatory cytokines IL-1 and TNF- have been detected in the vitreous of diabetic patients with retinopathy (10,11) and in diabetic rat retinas correlated with increased vascular permeability (12,40).”
BackgroundAnrather, J., Csizmadia, V., Soares, M. P., & Winkler, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13594 · Cited by 184
Role of Interleukin-1β in the Development of Retinopathy in Rats: Effect of Antioxidants
Kowluru, R. A., & Odenbach, S. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0633 · Cited by 164 · cited 1×
“Moreover, intravitreal administration of IL-1 increases vascular permeability, associated with nuclear factor-kappaB (NF- B) activation, increased leukocyte adhesion, and retinal capillary cell death (13,14).”
BackgroundMifepristone (RU486): A review
Mahajan, D. K., & London, S. N. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)00189-1 · Cited by 164 · cited 1×
“To investigate if the effect of dexamethasone was dependent on transcriptional activation by the glucocorticoid receptor, BRECs were pretreated with 5 mol/l RU486, a glucocorticoid receptor antagonist that inhibits the transactivation function of this receptor (35).”
MethodZhang, R., Xu, Y., Ekman, N., Wu, Z., Wu, J., Alitalo, K., & Min, W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310678200 · Cited by 163 · cited 3×
“PKC activation can occur downstream of the PI3K pathway (38), which has been shown to be activated by TNFin vascular endothelial cells (39).”
BackgroundFrey, R. S., Gao, X., Javaid, K., Siddiqui, S. S., Rahman, A., & Malik, A. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508810200 · Cited by 149
Bobrovnikova-Marjon, E. V., Marjon, P. L., Barbash, O., Vander Jagt, D. L., & Abcouwer, S. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0682 · Cited by 113 · cited 1×
“I B was expressed using the AdEasy adenoviral vector system, as described (34).”
MethodSelf-citationFelinski, E. A., Cox, A. E., Phillips, B. E., & Antonetti, D. A. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.01.002 · Cited by 111 · cited 1×
“RU486 alone had no effect on permeability and did not alter the TNF- response but did prevent the dexamethasone reduction in permeabilitiy as previously reported (36).”
ResultSelf-citationMapping the Blood Vessels with Paracellular Permeability in the Retinas of Diabetic Rats
Barber, A. J., & Antonetti, D. A. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0244 · Cited by 104
Self-citationVanGuilder, H. D., Brucklacher, R. M., Patel, K., Ellis, R. W., Freeman, W. M., & Barber, A. J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06322.x · Cited by 103 · cited 1×
“Quantitative real-time PCR (qPCR) analysis was performed using the 7,900 HT Sequence Detection System in 384-well optical plates using TaqMan Universal PCR Master Mix Assay-on-Demand and Assay-by-Design primers and probes (Applied Biosystems) as previously described (30).”
MethodHistamine, ZO-1 and increased blood-retinal barrier permeability in diabetic retinopathy.
Gardner, T. W. (1995) · PubMed · Cited by 79
Harhaj, N. S., Barber, A. J., & Antonetti, D. A. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10183 · Cited by 78 · cited 1×
“Tight junction protein cellular localization was evaluated by immunocytochemistry, as previously described (32).”
MethodSelf-citationdo Carmo, A., Cunha-Vaz, J. G., Carvalho, A. P., & Lopes, M. C. (1999) · Vision Research · doi:10.1016/s0042-6989(99)00117-0 · Cited by 76 · cited 1×
“Increased levels of interleukin-1 beta (IL-1 ) and tumor necrosis factor- (TNF- ) have been detected in the vitreous of diabetic patients with proliferative diabetic retinopathy (10,11) and in diabetic rat retinas (6,7,12).”
BackgroundSundstrom, J. M., Tash, B. R., Murakami, T., Flanagan, J. M., Bewley, M. C., Stanley, B. A., Gonsar, K. B., & Antonetti, D. A. (2009) · Journal of Proteome Research · doi:10.1021/pr7007913 · Cited by 75 · cited 1×
“Occludin becomes phosphorylated on multiple sites after VEGF treatment in a conventional PKC-dependent manner (23) and Ser490 has recently been identified as a phosphorylation site necessary for VEGF-induced permeability (24,45).”
BackgroundSelf-citationUltrastructural analysis of interleukin-1 beta-induced leukocyte recruitment to the rat retina.
Bamforth, S. D., Lightman, S., & Greenwood, J. A. (1997) · PubMed · Cited by 68
Cloning and characterization of the murine claudin-5 promoter
Burek, M., & Förster, C. Y. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.041 · Cited by 65 · cited 2×
“These studies are consistent with previous publications demonstrating reduced claudin-5 gene expression after TNF- treatment in brain capillary endothelial cells (42,43).”
BackgroundResultGarin, G., Abe, J., Mohan, A., Lu, W.-M., Chen, Y., Newby, A., Rhaman, A., & Berk, B. (2007) · Circulation Research · doi:10.1161/circresaha.107.148270 · Cited by 62
Criswell, T. L., & Arteaga, C. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704434200 · Cited by 60
Tomi, M., & Hosoya, K. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02842.x · Cited by 57
Saishin, Y., Saishin, Y., Takahashi, K., Melia, M., Vinores, S. A., & Campochiaro, P. A. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10238 · Cited by 52 · cited 1×
“TNF- also increases leukocyte adhesion to retinal endothelium (15) and blood–retinal barrier (BRB) permeability (16).”
BackgroundEffect of cyclosporin‐A on the blood–retinal barrier permeability in streptozotocin‐induced diabetes
do Carmo, A., Cunha-Vaz, J. G., Carvalho, A. P., & Lopes, M. C. (2000) · Mediators of Inflammation · doi:10.1080/09629350020025764 · Cited by 48
Diabetic macular oedema and visual loss: relationship to location, severity and duration
Gardner, T. W., Larsen, M., Girach, A., Zhi, X., & on behalf of the Protein Kinase C Diabetic Retinopathy Study (PKC‐DRS2) Study Group (2009) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2009.01545.x · Cited by 46
Ben-Mahmud, B. M., Mann, G. E., Datti, A., Orlacchio, A., KOHNER, E. M., & Chibber, R. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2968 · Cited by 45 · cited 1×
“TNF- also increases leukocyte adhesion to retinal endothelium (15) and blood–retinal barrier (BRB) permeability (16).”
BackgroundSander, B., Thornit, D. N., Colmorn, L. B., Strøm, C., Girach, A., Hubbard, L. D., Lund‐Andersen, H., & Larsen, M. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1102 · Cited by 42
Isolation and Characterization of Retinal Endothelial Cells
Antonetti, D. A., & Wolpert, E. B. (2003) · Humana Press eBooks · doi:10.1385/1-59259-419-0:365 · Cited by 30 · cited 1×
“Bovine retinal endothelial cells (BRECs) were isolated and grown as previously described (28), except medium was supplemented with 8 g/ml tylosin.”
MethodSelf-citation
Cited by
Antonetti, D. A., Klein, R., & Gardner, T. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1005073 · Cited by 1,659
Self-citationInflammation in diabetic retinopathy
Tang, J., & Kern, T. S. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.05.002 · Cited by 1,116
“TNFα likewise has been shown to increase retinal endothelial permeability increase via protein kinase C zeta (Aveleira et al., 2010).”
Mechanisms of macular edema: Beyond the surface
Daruich, A., Matet, A., Moulin, A., Kowalczuk, L., Nicolas, M., Sellam, A., Rothschild, P.-R., Omri, S., Gélizé, E., Jonet, L., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.006 · Cited by 708
Current understanding of the molecular and cellular pathology of diabetic retinopathy
Antonetti, D. A., Silva, P. S., & Stitt, A. W. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00451-4 · Cited by 645
Self-citationClaudin-5: gatekeeper of neurological function
Greene, C., Hanley, N., & Campbell, M. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0123-z · Cited by 583
Metadata
- Authors
- Aveleira, C. A., Lin, C.-M., Abcouwer, S. F., Ambrósio, A. F., & Antonetti, D. A.
- Affiliations
- Pennsylvania State University (US)
- Centro de Neurociências e Biologia Celular (PT)
- Corresponding author
- Aveleira, Célia A.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-08-06
- Volume
- 59
- Issue
- 11
- Pages
- 2872-2882
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2963546
- OpenAlex
- W2155144135
- Cited by
- 403
- References
- 57
- Citations by year
- 2026: 18 · 2025: 25 · 2024: 17 · 2023: 26 · 2022: 31 · 2021: 33 · 2020: 34 · 2019: 35 · 2018: 35 · 2017: 31 · 2016: 23 · 2015: 29 · 2014: 17 · 2013: 21 · 2012: 20
- FWCI
- 9.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Juvenile Diabetes Research Foundation International
- University of Pennsylvania
- Pennsylvania State University
- National Institutes of Health (012021)
- Penn State College of Medicine
- National Eye Institute (R01EY012021, R01EY016413)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- TNF-α, IL-1β, tight junction proteins, ZO-1, claudin-5, protein kinase C, NF-κB signaling, dexamethasone, glucocorticoid receptor, IκBα, diabetic retinopathy, retinal vascular permeability, IKK inhibitor
- MeSH terms
- Protein Kinase C zeta, Animals, Cattle, Cell Membrane Permeability, Dexamethasone, Diabetic Retinopathy, Humans, Male, Permeability, Protein Kinase C, Retina, Retinal Diseases, Tumor Necrosis Factor-alpha, NF-kappa B, Rats, Sprague-Dawley, Tight Junctions, Endothelial Cells, Rats, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.